Sunset Island Group, Inc. (SIGO) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
Beta 1.76: the stock has moved about 76% more than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerSunset Island Group, Inc. (SIGO) trades at $0.0001. Sunset Island Group, Inc. (SIGO) operates in the healthcare sector, focusing on medicinal cannabis cultivation in California through its VBF Brands subsidiary. Sector: Healthcare.
Price as of · Last analyzed: Jun 15, 2026Analyst Coverage for SIGO: SIGO does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
Sunset Island Group, Inc. (SIGO) Healthcare & Pipeline Overview
Sunset Island Group, Inc. (SIGO), established in 2005, operates within the healthcare sector as a specialty and generic drug manufacturer, specifically focusing on medicinal cannabis. Through its VBF Brands subsidiary, the company cultivates medicinal cannabis across California and provides essential advisory and support services to other medical marijuana enterprises, positioning itself in a specialized, regulated market.
What Is the Investment Thesis for SIGO?
Sunset Island Group, Inc. (SIGO) presents a focused investment profile within California's medicinal cannabis sector, operating through its VBF Brands subsidiary for cultivation and offering advisory services. A key value driver is the company's reported gross margin of 79.7%, which suggests efficient production or strong pricing power within its specific market segment, despite a negative profit margin of -49.5%. This indicates that while operational costs beyond the cost of goods sold are significant, the core business of cultivation and services generates substantial revenue relative to direct production expenses. Growth catalysts include the ongoing expansion and maturation of the medicinal cannabis market in California, potentially leading to increased demand for both cultivated products and specialized advisory services. The company's established presence since 2005 and its localized operations in San Clemente provide a foundation for navigating the state's regulatory landscape. However, the company's $0.00B market capitalization and a Beta of 1.76 highlight its small scale and high volatility, respectively. The "OTC Other" listing also implies inherent risks related to liquidity and disclosure. Future performance will depend on its ability to scale operations, improve overall profitability, and adapt to evolving regulatory frameworks within the dynamic cannabis industry.
Based on FMP financials and quantitative analysis
SIGO Key Highlights
Market Capitalization: $0.00B, reflecting a micro-cap valuation.
- Gross Margin: 79.7%, indicating strong profitability on direct production costs for its medicinal cannabis and services.
- Profit Margin: -49.5%, suggesting significant operational expenses beyond cost of goods sold, leading to overall unprofitability.
- Beta: 1.76, signifying higher volatility compared to the broader market.
- Employee Base: 6 employees, indicating a lean operational structure for its cultivation and advisory services.
Who Are SIGO's Competitors?
SIGO is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| AKAN Akanda Corp. | $1.98 | -10.41% | — | |
| SNOA Sonoma Pharmaceuticals, Inc. | $1.24 | -0.80% | $5.94M | — |
| BFRI Biofrontera Inc. | $1.01 | -2.40% | $13.0M | — |
| COSM COSM | $0.38 | -1.58% | $20.7M | — |
| QNTM Quantum BioPharma Ltd. | $3.44 | +0.44% | $22.0M | — |
| AYTU Aytu BioPharma, Inc. | $2.07 | -0.96% | $22.2M | — |
| TXMD TherapeuticsMD, Inc. | $2.05 | +0.99% | $23.7M | — |
| CPHI CPHI | $0.66 | +0.61% | $26.6M | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are SIGO's Key Strengths?
Established operations in California's medicinal cannabis sector since 2005.
- High gross margin of 79.7% on its core cultivation and service activities.
- Dual business model offering both cultivation and advisory services, diversifying revenue potential.
- Focused niche in the regulated California medical marijuana market.
What Are SIGO's Weaknesses?
Negative profit margin of -49.5%, indicating significant operating expenses relative to revenue.
- Very small scale with only 6 employees and a $0.00B market capitalization.
- "OTC Other" listing, implying limited liquidity and transparency.
- "Unknown" disclosure status, posing challenges for investor due diligence.
What Are the Key Risks for SIGO?
Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- **Ongoing:** Intense competition within the California medicinal cannabis market, potentially impacting pricing power and market share.
- **Potential:** Adverse changes in state or federal regulations concerning cannabis, which could impact cultivation, distribution, or advisory services.
- **Ongoing:** Financial performance challenges, as indicated by the negative profit margin of -49.5%, posing risks to long-term sustainability.
- **Ongoing:** Limited liquidity and high volatility associated with its "OTC Other" listing, making it difficult for investors to trade shares efficiently.
- **Potential:** Dependence on the specific market dynamics of California's medicinal cannabis sector, making the company susceptible to regional market shifts.
What Threats Does SIGO Face?
- Intense competition from other licensed cannabis cultivators and service providers.
- Evolving and potentially restrictive regulatory changes in the cannabis industry.
- Market volatility and price fluctuations for medicinal cannabis products.
- Limited access to capital for expansion due to its small size and OTC listing.
What Are SIGO's Competitive Advantages?
- Established presence and operational experience in the California medicinal cannabis market since 2005.
- Expertise in navigating the complex and evolving regulatory landscape for cannabis cultivation and business operations in California.
- Dual business model combining cultivation with specialized advisory services, creating synergistic value.
- Localized operations in San Clemente, California, providing proximity to market dynamics and regulatory bodies.
What Does SIGO Do?
Sunset Island Group, Inc. (SIGO), headquartered in San Clemente, California, was established in 2005 and operates primarily within the healthcare sector, specifically the niche of drug manufacturers specializing in medicinal cannabis. The company’s core operations are conducted through its wholly-owned subsidiary, VBF Brands. VBF Brands is dedicated to the cultivation of medicinal cannabis throughout various regions of California, a state known for its established and evolving medical marijuana market. This cultivation focus positions SIGO as a direct participant in the supply chain for medicinal cannabis products, catering to the needs of patients and dispensaries within the state. Beyond its cultivation activities, Sunset Island Group, Inc. extends its expertise to the broader medical marijuana sector by providing advisory and support services. These services are designed to assist various enterprises active in this specialized industry, potentially covering areas such as regulatory compliance, operational best practices, market entry strategies, and supply chain management. This dual approach of cultivation and professional services allows SIGO to leverage its operational knowledge and experience, offering value to both the production and strategic development aspects of the medical cannabis industry. With its principal office in San Clemente, the company maintains a localized presence in California, enabling it to closely monitor and respond to the specific regulatory and market dynamics of the state. The company, with its 6 employees, focuses on a specialized segment of the healthcare market, aiming to contribute to the regulated supply of medicinal cannabis and support the growth of related businesses. Its operational model is centered on navigating the complexities of cannabis cultivation and business development within a regulated framework.
What Products and Services Does SIGO Offer?
- Cultivates medicinal cannabis throughout California via its subsidiary, VBF Brands.
- Provides advisory services to various enterprises within the medical marijuana sector.
- Offers support services to businesses operating in the medical marijuana industry.
- Focuses on the regulated medicinal cannabis market in California.
- Aims to contribute to the supply chain of medical cannabis products.
- Assists other medical marijuana businesses with operational and strategic guidance.
How Does SIGO Make Money?
- Generates revenue from the sale of cultivated medicinal cannabis products.
- Earns fees from providing advisory services to medical marijuana enterprises.
- Receives compensation for offering support services to businesses in the sector.
- Operates within a regulated market framework in California.
What Industry Does SIGO Operate In?
Sunset Island Group, Inc. (SIGO) operates within the "Drug Manufacturers - Specialty & Generic" industry, specifically carving out a niche in the medicinal cannabis sub-sector in California. The broader cannabis market, particularly for medicinal use, has seen significant growth driven by evolving legal frameworks and increasing patient acceptance. California, as one of the largest and most established cannabis markets globally, offers a substantial operational environment for companies like SIGO. The competitive landscape for medicinal cannabis cultivation includes numerous licensed growers, ranging from small-scale operations to larger, more capitalized entities. For advisory and support services, SIGO competes with specialized consultants and legal firms catering to the cannabis industry. SIGO's positioning is defined by its dual focus on cultivation through VBF Brands and providing expert services, aiming to leverage its operational experience within this highly regulated and dynamic market. The industry is characterized by stringent regulatory compliance, supply chain complexities, and price fluctuations, all of which influence the operational environment for SIGO.
Who Are SIGO's Key Customers?
- Licensed medicinal cannabis dispensaries in California.
- Patients who consume medicinal cannabis (indirectly, through dispensaries).
- Other businesses and enterprises operating in the medical marijuana sector seeking advisory and support services.
- Cultivators and processors requiring guidance on compliance and operations.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Company Profile
Sunset Island Group, Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Salinas, US. The company is led by CEO Valerie Baugher. SIGO has traded publicly since 2017.
Key Financial Metrics
Return on equity for Sunset Island Group, Inc. stands at 17.3%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -97.5%, showing how much profit it generates from its asset base. A current ratio of 0.13 means current liabilities exceed short-term assets, a liquidity point worth watching.
Financial Health
Sunset Island Group, Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
SIGO Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
SIGO Latest News
No recent news available for SIGO.
SIGO Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for SIGO.
Price Targets
Wall Street price target analysis for SIGO.
SIGO MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for SIGO; grades run from A+ (80-100) to F (below 30).
Leadership: Valerie Baugher
Chief Executive Officer
Valerie Baugher serves as the leader of Sunset Island Group, Inc., overseeing its operations and strategic direction. Her role involves managing the company's 6 employees, indicating direct involvement in the day-to-day operations and strategic oversight of both the VBF Brands medicinal cannabis cultivation and the advisory services segments in California.
Track Record: Under Valerie Baugher's leadership, Sunset Island Group, Inc. has maintained its operational focus on medicinal cannabis cultivation through VBF Brands and the provision of advisory services in California since its establishment in 2005. Her management has guided the company in navigating the complexities of the medical marijuana sector, evidenced by its continued operation. The company's reported gross margin of 79.7% reflects operational efficiency in its core business activities during her tenure.
SIGO OTC Market Information
Sunset Island Group, Inc. (SIGO) is listed on the "OTC Other" tier of the OTC Markets. This tier is typically for companies that do not meet the minimum financial or disclosure standards of higher tiers like OTCQX or OTCQB, nor do they trade on major exchanges such as the NYSE or NASDAQ. Companies on OTC Other are not required to report to the SEC, resulting in significantly less public information and transparency compared to exchange-listed or even higher-tier OTC companies. This classification often indicates a micro-cap or penny stock, carrying higher inherent risks for investors due to limited regulatory oversight and disclosure requirements.
- OTC Tier: OTC Other
- Limited transparency due to "Unknown" disclosure status and lack of SEC reporting requirements for OTC Other.
- High price volatility and potential for significant price swings due to low trading volume and limited market depth.
- Challenges in obtaining reliable and timely financial information for informed decision-making.
- Increased risk of market manipulation due to lower regulatory oversight and smaller market capitalization.
- Difficulty in valuation given the absence of comprehensive financial data and analyst coverage.
- Verify any available financial statements or reports directly from the company or third-party sources.
- Research the background and track record of management, including Valerie Baugher.
- Investigate the specific licenses and regulatory compliance status of VBF Brands in California.
- Assess the competitive landscape and market trends within the California medicinal cannabis sector.
- Examine any news or press releases for operational updates, partnerships, or legal developments.
- Understand the specific risks associated with investing in OTC Other securities.
- Consult legal and financial professionals familiar with micro-cap and cannabis investments.
- Established in 2005, indicating a long operational history, albeit in a niche market.
- Specific business operations in medicinal cannabis cultivation and advisory services, rather than a vague business plan.
- Identified physical headquarters in San Clemente, California.
- Named CEO, Valerie Baugher, providing a point of contact for leadership.
- Operates through a named subsidiary, VBF Brands, suggesting a structured corporate entity.
SIGO Healthcare Stock FAQ
What are the key financial characteristics of Sunset Island Group, Inc. (SIGO)?
Sunset Island Group, Inc. exhibits distinct financial characteristics. The company reports a notable gross margin of 79.7%, indicating strong profitability on its direct costs of goods sold for medicinal cannabis cultivation and advisory services.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Information is based solely on the provided source data. No external research or speculation has been included. The AI Insight provided in the source contained information about the real estate and hospitality sector which was inconsistent with the detailed business description; therefore, the business description was prioritized for accuracy. Lack of specific competitor tickers, detailed CEO background, and analyst coverage impacts the depth of certain sections.